RxDoctor Payments Data

Jennifer Knapp

Family · Simpsonville, SCNPI 1720497837

Payments from drug & device makers

$1,204in general payments, 2019–2025

Across 63 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$196
  • AbbVie$155
  • Novo Nordisk$145
  • AstraZeneca$140
  • GSK$103
  • Daiichi Sankyo Inc.$95
  • plus $369 from 12 others

What the payments were for

  • Food & beverage$1,204100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,204 in reported general payments places this provider in the 70th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$37,015
Medicare patients
86
Services billed
781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$44,887
MounjaroTirzepatide20$25,654
JardianceEmpagliflozin19$25,404
RybelsusSemaglutide13$19,553
XareltoRivaroxaban13$8,036
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,708
SynthroidLevothyroxine Sodium22$1,342
Rosuvastatin Calcium111$928
Montelukast Sodium44$816
Ezetimibe20$615
Atorvastatin Calcium102$600
Wixela InhubFluticasone Propion/Salmeterol12$560
Omeprazole61$532
Propranolol Hcl ErPropranolol Hcl11$473
Levothyroxine Sodium81$421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$145$64,44038 claims
Lilly USA, LLCMounjaro$196$25,65420 claims
Boehringer IngelheimJardiance$13$25,40419 claims
Johnson & JohnsonXarelto$26$8,03613 claims
GSKTrelegy Ellipta$103$7,70812 claims
AbbVieSynthroid$155$1,34222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,248 family providers in South Carolina.

Other family in Simpsonville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →